Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.

Muňoz FM, Swamy GK, Hickman SP, Agrawal S, Piedra PA, Glenn GM, Patel N, August AM, Cho I, Fries L.

J Infect Dis. 2019 Oct 22;220(11):1802-1815. doi: 10.1093/infdis/jiz390.

PMID:
31402384
2.

Ketalization of 2-heptanone to prolong its activity as mite repellant for the protection of honey bees.

Borries FA, Kudla AM, Kim S, Allston TD, Eddingsaas NC, Shey J, Orts WJ, Klamczynski AP, Glenn GM, Miri MJ.

J Sci Food Agric. 2019 Nov;99(14):6267-6277. doi: 10.1002/jsfa.9900. Epub 2019 Aug 12.

PMID:
31259414
3.

Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.

Shinde V, Fries L, Wu Y, Agrawal S, Cho I, Thomas DN, Spindler M, Lindner E, Hahn T, Plested J, Flyer D, Massare MJ, Zhou B, Fix A, Smith G, Glenn GM.

N Engl J Med. 2018 Jun 14;378(24):2346-2348. doi: 10.1056/NEJMc1803554. No abstract available.

4.

Solution blow spun nanocomposites of poly(lactic acid)/cellulose nanocrystals from Eucalyptus kraft pulp.

Parize DDDS, Oliveira JE, Williams T, Wood D, Avena-Bustillos RJ, Klamczynski AP, Glenn GM, Marconcini JM, Mattoso LHC.

Carbohydr Polym. 2017 Oct 15;174:923-932. doi: 10.1016/j.carbpol.2017.07.019. Epub 2017 Jul 10.

PMID:
28821149
5.

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM.

Virology. 2017 Sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. Epub 2017 Jun 16.

6.

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.

August A, Glenn GM, Kpamegan E, Hickman SP, Jani D, Lu H, Thomas DN, Wen J, Piedra PA, Fries LF.

Vaccine. 2017 Jun 27;35(30):3749-3759. doi: 10.1016/j.vaccine.2017.05.045. Epub 2017 Jun 1.

7.

Solution Blow Spinning of Food-Grade Gelatin Nanofibers.

Liu F, Avena-Bustillos RJ, Bilbao-Sainz C, Woods R, Chiou BS, Wood D, Williams T, Yokoyama W, Glenn GM, McHugh TH, Zhong F.

J Food Sci. 2017 Jun;82(6):1402-1411. doi: 10.1111/1750-3841.13710. Epub 2017 May 4.

PMID:
28471491
8.

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.

Fries L, Shinde V, Stoddard JJ, Thomas DN, Kpamegan E, Lu H, Smith G, Hickman SP, Piedra P, Glenn GM.

Immun Ageing. 2017 Apr 12;14:8. doi: 10.1186/s12979-017-0090-7. eCollection 2017.

9.

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.

Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, Frieman MB.

Vaccine. 2017 Mar 14;35(12):1586-1589. doi: 10.1016/j.vaccine.2017.02.012. Epub 2017 Feb 23.

10.

Preparation of Zein Fibers Using Solution Blow Spinning Method.

Liu F, Avena-Bustillos RJ, Woods R, Chiou BS, Williams TG, Wood DF, Bilbao-Sainz C, Yokoyama W, Glenn GM, McHugh TH, Zhong F.

J Food Sci. 2016 Dec;81(12):N3015-N3025. doi: 10.1111/1750-3841.13537. Epub 2016 Nov 9.

PMID:
27861896
11.

Controlled Release of Linalool Using Nanofibrous Membranes of Poly(lactic acid) Obtained by Electrospinning and Solution Blow Spinning: A Comparative Study.

Souza MA, Oliveira JE, Medeiros ES, Glenn GM, Mattoso LH.

J Nanosci Nanotechnol. 2015 Aug;15(8):5628-36.

PMID:
26369129
12.

Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs.

Glenn GM, Fries LF, Smith G, Kpamegan E, Lu H, Guebre-Xabier M, Hickman SP, Flyer D.

Vaccine. 2015 Nov 25;33(47):6488-92. doi: 10.1016/j.vaccine.2015.08.039. Epub 2015 Aug 28.

13.

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

Glenn GM, Fries LF, Thomas DN, Smith G, Kpamegan E, Lu H, Flyer D, Jani D, Hickman SP, Piedra PA.

J Infect Dis. 2016 Feb 1;213(3):411-22. doi: 10.1093/infdis/jiv406. Epub 2015 Aug 10.

PMID:
26259809
14.

Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.

Liu YV, Massare MJ, Pearce MB, Sun X, Belser JA, Maines TR, Creager HM, Glenn GM, Pushko P, Smith GE, Tumpey TM.

Vaccine. 2015 Apr 27;33(18):2152-8. doi: 10.1016/j.vaccine.2015.03.009. Epub 2015 Mar 13.

15.

In vitro antimicrobial activity of solution blow spun poly(lactic acid)/polyvinylpyrrolidone nanofibers loaded with Copaiba (Copaifera sp.) oil.

Bonan RF, Bonan PR, Batista AU, Sampaio FC, Albuquerque AJ, Moraes MC, Mattoso LH, Glenn GM, Medeiros ES, Oliveira JE.

Mater Sci Eng C Mater Biol Appl. 2015 Mar;48:372-7. doi: 10.1016/j.msec.2014.12.021. Epub 2014 Dec 9.

PMID:
25579936
16.

Torrefaction of pomaces and nut shells.

Chiou BS, Valenzuela-Medina D, Bilbao-Sainz C, Klamczynski AK, Avena-Bustillos RJ, Milczarek RR, Du WX, Glenn GM, Orts WJ.

Bioresour Technol. 2015 Feb;177:58-65. doi: 10.1016/j.biortech.2014.11.071. Epub 2014 Nov 20.

PMID:
25479394
17.

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.

Raghunandan R, Lu H, Zhou B, Xabier MG, Massare MJ, Flyer DC, Fries LF, Smith GE, Glenn GM.

Vaccine. 2014 Nov 12;32(48):6485-92. doi: 10.1016/j.vaccine.2014.09.030. Epub 2014 Sep 28.

18.

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, DuPont HL.

Lancet Infect Dis. 2014 Mar;14(3):197-204. doi: 10.1016/S1473-3099(13)70297-4. Epub 2013 Nov 29.

PMID:
24291168
19.

A recombinant viruslike particle influenza A (H7N9) vaccine.

Fries LF, Smith GE, Glenn GM.

N Engl J Med. 2013 Dec 26;369(26):2564-6. doi: 10.1056/NEJMc1313186. Epub 2013 Nov 13. No abstract available.

20.

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF 3rd, Glenn GM.

Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26.

21.

Cutaneous vaccination: antigen delivery into or onto the skin.

Weniger BG, Glenn GM.

Vaccine. 2013 Jul 25;31(34):3389-91. doi: 10.1016/j.vaccine.2013.05.048. Epub 2013 May 16. No abstract available.

PMID:
23684830
22.

Brucite nanoplates reinforced starch bionanocomposites.

Moreira FK, Pedro DC, Glenn GM, Marconcini JM, Mattoso LH.

Carbohydr Polym. 2013 Feb 15;92(2):1743-51. doi: 10.1016/j.carbpol.2012.11.019. Epub 2012 Nov 14.

PMID:
23399215
23.

Solid lipid particles in lipid films to control the diffusive release of 2-heptanone.

Bilbao-Sáinz C, Chiou BS, Glenn GM, Gregorsky KS, Williams TG, Wood DF, Klamczynski AP, Orts WJ.

Pest Manag Sci. 2013 Aug;69(8):975-82. doi: 10.1002/ps.3462. Epub 2013 Jan 28.

PMID:
23355371
24.

Properties of electrospun pollock gelatin/poly(vinyl alcohol) and pollock gelatin/poly(lactic acid) fibers.

Chiou BS, Jafri H, Avena-Bustillos R, Gregorski KS, Bechtel PJ, Imam SH, Glenn GM, Orts WJ.

Int J Biol Macromol. 2013 Apr;55:214-20. doi: 10.1016/j.ijbiomac.2013.01.010. Epub 2013 Jan 23.

PMID:
23352992
25.

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.

Glenn GM, Smith G, Fries L, Raghunandan R, Lu H, Zhou B, Thomas DN, Hickman SP, Kpamegan E, Boddapati S, Piedra PA.

Vaccine. 2013 Jan 7;31(3):524-32. doi: 10.1016/j.vaccine.2012.11.009. Epub 2012 Nov 12.

PMID:
23153449
26.

Use of microscopy to assess bran removal patterns in milled rice.

Wood DF, Siebenmorgen TJ, Williams TG, Orts WJ, Glenn GM.

J Agric Food Chem. 2012 Jul 18;60(28):6960-5. doi: 10.1021/jf301263s. Epub 2012 Jul 2.

PMID:
22642895
27.

Close ties: an exploratory Colored Eco-Genetic Relationship Map (CEGRM) study of social connections of men in Familial Testicular Cancer (FTC) families.

Peters JA, Kenen R, Hoskins LM, Glenn GM, Kratz C, Greene MH.

Hered Cancer Clin Pract. 2012 Mar 1;10:2. doi: 10.1186/1897-4287-10-2.

28.

The 'perfect' adjuvant, a stronger voice.

Glenn GM.

Expert Rev Vaccines. 2011 Apr;10(4):399-400. doi: 10.1586/erv.11.38. No abstract available.

PMID:
21506634
29.

Encapsulation of plant oils in porous starch microspheres.

Glenn GM, Klamczynski AP, Woods DF, Chiou B, Orts WJ, Imam SH.

J Agric Food Chem. 2010 Apr 14;58(7):4180-4. doi: 10.1021/jf9037826.

PMID:
20196603
30.

Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch.

Glenn GM, Thomas DN, Poffenberger KL, Flyer DC, Ellingsworth LR, Andersen BH, Frech SA.

Vaccine. 2009 Dec 30;27 Suppl 6:G60-6. doi: 10.1016/j.vaccine.2009.10.031.

PMID:
20006142
31.

Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines.

Glenn GM, Francis DH, Danielsen EM.

Infect Immun. 2009 Dec;77(12):5206-15. doi: 10.1128/IAI.00712-09. Epub 2009 Sep 8. Review.

32.

Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.

Stewart L, Glenn GM, Stratton P, Goldstein AM, Merino MJ, Tucker MA, Linehan WM, Toro JR.

Arch Dermatol. 2008 Dec;144(12):1584-92. doi: 10.1001/archdermatol.2008.517.

33.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Meléndez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM.

Lancet. 2008 Jun 14;371(9629):2019-25. doi: 10.1016/S0140-6736(08)60839-9.

PMID:
18554712
34.

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch.

Frerichs DM, Ellingsworth LR, Frech SA, Flyer DC, Villar CP, Yu J, Glenn GM.

Vaccine. 2008 May 23;26(22):2782-7. doi: 10.1016/j.vaccine.2008.02.070. Epub 2008 Mar 28.

PMID:
18455283
35.

Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch.

Frolov VG, Seid RC Jr, Odutayo O, Al-Khalili M, Yu J, Frolova OY, Vu H, Butler BA, Look JL, Ellingsworth LR, Glenn GM.

Influenza Other Respir Viruses. 2008 Mar;2(2):53-60. doi: 10.1111/j.1750-2659.2008.00040.x.

36.

BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.

Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM.

J Med Genet. 2008 Jun;45(6):321-31. doi: 10.1136/jmg.2007.054304. Epub 2008 Jan 30. Review.

37.

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).

Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, Bartlett DL, Glenn GM, Middelton L, Linehan WM, Libutti SK.

Surgery. 2007 Dec;142(6):814-8; discussion 818.e1-2. Erratum in: Surgery. 2008 Feb;143(2):302.

38.

Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.

Mkrtichyan M, Ghochikyan A, Movsesyan N, Karapetyan A, Begoyan G, Yu J, Glenn GM, Ross TM, Agadjanyan MG, Cribbs DH.

DNA Cell Biol. 2008 Jan;27(1):19-24.

39.

Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch.

Glenn GM, Flyer DC, Ellingsworth LR, Frech SA, Frerichs DM, Seid RC, Yu J.

Expert Rev Vaccines. 2007 Oct;6(5):809-19. Review.

PMID:
17931160
40.

Adjuvants: progress, regress and pandemic preparedness.

Glenn GM, O'Hagan DT.

Expert Rev Vaccines. 2007 Oct;6(5):651-2. No abstract available.

PMID:
17931144
41.

Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.

Grubb RL 3rd, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM.

J Urol. 2007 Jun;177(6):2074-9; discussion 2079-80.

PMID:
17509289
42.

Heat expanded starch-based compositions.

Glenn GM, Klamczynski AK, Holtman KM, Shey J, Chiou BS, Berrios J, Wood D, Orts WJ, Imam SH.

J Agric Food Chem. 2007 May 16;55(10):3936-43. Epub 2007 Apr 14.

PMID:
17432870
43.

Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome.

Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM.

Am J Respir Crit Care Med. 2007 May 15;175(10):1044-53. Epub 2007 Feb 22.

44.

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

McKenzie R, Bourgeois AL, Frech SA, Flyer DC, Bloom A, Kazempour K, Glenn GM.

Vaccine. 2007 May 4;25(18):3684-91. Epub 2007 Jan 23.

PMID:
17313998
45.

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.

Glenn GM, Villar CP, Flyer DC, Bourgeois AL, McKenzie R, Lavker RM, Frech SA.

Infect Immun. 2007 May;75(5):2163-70. Epub 2007 Jan 29.

46.

Mass vaccination: solutions in the skin.

Glenn GM, Kenney RT.

Curr Top Microbiol Immunol. 2006;304:247-68. Review.

PMID:
16989274
47.

GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant.

Zoeteweij JP, Epperson DE, Porter JD, Zhang CX, Frolova OY, Constantinides AP, Fuhrmann SR, El-Amine M, Tian JH, Ellingsworth LR, Glenn GM.

J Immunol. 2006 Jul 15;177(2):1197-207.

48.

Permeability of starch gel matrices and select films to solvent vapors.

Glenn GM, Klamczynski AP, Ludvik C, Shey J, Imam SH, Chiou BS, McHugh T, DeGrandi-Hoffman G, Orts W, Wood D, Offeman R.

J Agric Food Chem. 2006 May 3;54(9):3297-304.

PMID:
16637688
49.

Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer.

Pithukpakorn M, Wei MH, Toure O, Steinbach PJ, Glenn GM, Zbar B, Linehan WM, Toro JR.

J Med Genet. 2006 Sep;43(9):755-62. Epub 2006 Apr 5.

50.

Advances in vaccine delivery: transcutaneous immunisation.

Glenn GM, Scharton-Kersten T, Alving CR.

Expert Opin Investig Drugs. 1999 Jun;8(6):797-805.

PMID:
15992132

Supplemental Content

Loading ...
Support Center